RoyceDerm Seborrheic Dermatitis and Psoriasis shampoo. 7.5 g/250g
Salicylic Acid 3% · SHAMPOO · RoyceDerm LLC
Roycederm is a shampoo containing 3% salicylic acid used to treat seborrheic dermatitis and psoriasis of the scalp. It is available over the counter without a prescription.
Key Facts
- Brand Name
- RoyceDerm Seborrheic Dermatitis and Psoriasis shampoo.
- Generic Name
- Salicylic Acid 3%
- NDC Code (Product)
85424-015- Manufacturer
- RoyceDerm LLC
- Strength
- 7.5 g/250g
- Dosage Form
- SHAMPOO
- Route
- TOPICAL
- Marketing Status
- Application #
- M032
- Marketing Start
- 02/20/2026
Recall History
No Recall HistoryFrequently Asked Questions
What is RoyceDerm Seborrheic Dermatitis and Psoriasis shampoo. used for?
Roycederm is a shampoo containing 3% salicylic acid used to treat seborrheic dermatitis and psoriasis of the scalp. It is available over the counter without a prescription.
Is RoyceDerm Seborrheic Dermatitis and Psoriasis shampoo. a controlled substance?
RoyceDerm Seborrheic Dermatitis and Psoriasis shampoo. is not classified as a controlled substance by the DEA.
What is the generic name for RoyceDerm Seborrheic Dermatitis and Psoriasis shampoo.?
The generic name for RoyceDerm Seborrheic Dermatitis and Psoriasis shampoo. is Salicylic Acid 3%. There are 6 other brand versions of Salicylic Acid 3%.
What is the NDC code for RoyceDerm Seborrheic Dermatitis and Psoriasis shampoo. 7.5 g/250g?
The NDC (National Drug Code) for RoyceDerm Seborrheic Dermatitis and Psoriasis shampoo. 7.5 g/250g is 85424-015, listed by RoyceDerm LLC.
Other Salicylic Brands
See all →- Scalp Revival3 g/100mL82594-001
- RoyceDerm Seborrheic Dermatitis and Psoriasis Treatment cream3 g/100g85424-014
- RoyceDerm Seborrheic Dermatitis and Psoriasis Shampoo.7.5 g/250g85424-020
- RoyceDerm Seborrheic Dermatitis and Psoriasis Treatment cream3 g/100g85424-017
- RoyceDerm Tea Tree Therapeutic3 mg/100mL85424-012
- ProBliva Psoriasis Scalp .spray.3.6 g/120g85464-005
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)